The Heparin-Induced Thrombocytopenia (HIT) Treatment Market Size is valued at USD 9.38 billion in 2023 and is predicted to reach USD 13.55 billion by the year 2031 at a 4.81% CAGR during the forecast period for 2024-2031. Heparin-induced thrombocytopenia refers to a complication, such as pulmonary embolism, acute myocardial infarction, deep venous thrombotic stroke, etc., that can occur in patients due to taking heparin products. Hence, the ad...
Report ID: 2877 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 165
The Gene Therapies For Rare Diseases Market is expected to grow at an 20.0 % CAGR during the forecast period for 2023-2031. Gene Therapy is playing a major role in rare disease management. Gene therapy in rare diseases is a specialized and targeted treatment that acts via the insertion of corrected genes into cells of an individual. Around 80 percent of rare diseases are accounted with genetic etiology. Gene therapy is considered as proven wit...
Report ID: 1091 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 185
The Gene Therapy For Retinal Diseases Market is expected to grow at an 8.0 % CAGR during the forecast period for 2023-2031. Gene therapy states a method of announcing foreign DNA constructs into host cells in demand to treat various medical conditions, including retinal diseases. Gene therapy has an increasing research potential, mainly in the arena of retinal and ophthalmic diseases. The main features of the eye include convenience in terms o...
Report ID: 1157 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
The Celiac Disease Market Size is valued at USD 581.6 Mn in 2023 and is predicted to reach USD 1,195.5 Mn by the year 2031 at a 9.8% CAGR during the forecast period for 2024-2031. Celiac disease is an autoimmune disorder in which gluten consumption triggers an immune response that destroys the small intestine lining. This damage limits proper nutritional absorption from meals, causing various symptoms and perhaps long-term health effects. Celi...
Report ID: 2874 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 168
The Fibrotic Diseases Treatment Market Size is valued at USD 3.57 billion in 2023 and is predicted to reach USD 5.40 billion by the year 2031 at a 5.53% CAGR during the forecast period for 2024-2031. Treatment for fibrotic Diseases aims to manage and decelerate the progression of fibrosis, a condition characterized by the accumulation of extra connective tissue in organs, resulting in scarring and diminished functionality. These disorders...
Report ID: 2876 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 165
The Pharmaceutical Fluid Handling Market Size is valued at USD 10.28 Bn in 2022 and is predicted to reach USD 15.31 Bn by the year 2031 at a 4.6% CAGR during the forecast period for 2023-2031. Pharmaceutical fluid handling is essential for delivering fluid medications such as cough syrups, intravenous medicines, and complicated active pharmaceutical components. Any firm that wants to flourish and be relied upon must invest in properly handling...
Report ID: 2048 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
The Phenobarbital Market Size is valued at USD 1.48 Bn in 2022 and is predicted to reach USD 2.20 Bn by the year 2031 at a 4.6% CAGR during the forecast period for 2023-2031. Phenobarbital acts as a central nervous system depressant. It enhances the activity of a neurotransmitter called gamma-aminobutyric acid (GABA), which inhibits brain activity. This results in a calming effect on the brain, making it useful for conditions involving seizure...
Report ID: 2049 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
Rare Gastrointestinal Diseases Treatment Market Size is valued at USD 1.29 Bn in 2022 and is predicted to reach USD 1.68 Bn by the year 2031 at a 3.1% CAGR during the forecast period for 2023-2031. Rare gastrointestinal disorders are those that affect the GI (gastrointestinal tract) from the mouth to the anus. Rare gastrointestinal illnesses can be somewhat uncomfortable, severe, or even fatal. Achalasia, celiac disease, Ménétrie...
Report ID: 2075 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 179
Endothelial Dysfunction Market Size is valued at USD 1.84 Bn in 2022 and is predicted to reach USD 2.63 Bn by the year 2031 at a 4.1% CAGR during the forecast period for 2023-2031. Endothelial dysfunction is a condition characterised by impaired or compromised functioning of the inner lining of blood vessels, the endothelium. The endothelium is essential for sustaining vascular health and regulating multiple physiological processes. The growt...
Report ID: 2082 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 179
The preceding decades have shown higher incidence and prevalence trends for cancer. Globally, the scenario is worsening with the mounting number of cancer patients every year. The number of new cancer cases is predicted to rise by 54% within the next two decades. In economically developing countries, adoption of western lifestyles, such as smoking, poor diet, physical inactivity, and fewer childbirths, will gradually increase the burden of the tr...
Report ID: 1066 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 140
Pharmaceuticals